No article text was recorded for this version.
drug discovery inefficiency
Version 1 of 1187 papers200 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Large Language Models in Drug Discovery and Development: From Disease Mechanisms to Clinical Trials
- Blog: Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions
- Blog: Multiple machine learning methods aided virtual screening of <scp>Na<sub>V</sub>1</scp>.5 inhibitors
- Blog: A Deep-Learning View of Chemical Space Designed to Facilitate Drug Discovery
- Blog: A Review on Applications of Computational Methods in Drug Screening and Design
- Blog: Youthful and age‐related matreotypes predict drugs promoting longevity
- Blog: Genomes, structural biology and drug discovery: combating the impacts of mutations in genetic disease and antibiotic resistance
- Blog: Computational drug repurposing in Parkinson’s disease: Omaveloxolone and cyproheptadine as promising therapeutic candidates
- Blog: The Application of Artificial Intelligence in Drug Discovery: Opportunities and Challenges
- Blog: Next Decade’s AI-Based Drug Development Features Tight Integration of Data and Computation
- Blog: Large language models for drug discovery and development
- Blog: Cancer drug discovery as a low rank tensor completion problem
- Blog: Computational Drug Repurposing for Alzheimer’s Disease Using Risk Genes From GWAS and Single-Cell RNA Sequencing Studies
- Blog: Causal reasoning over knowledge graphs leveraging drug-perturbed and disease-specific transcriptomic signatures for drug discovery
- Blog: PubChemQC PM6: Data Sets of 221 Million Molecules with Optimized Molecular Geometries and Electronic Properties
- Blog: Support Vector Machine as a Supervised Learning for the Prioritization of Novel Potential SARS-CoV-2 Main Protease Inhibitors
- Blog: MORGaN: self-supervised multi-relational graph learning for drug target discovery
- Blog: Predicting mechanism of action of novel compounds using compound structure and transcriptomic signature coembedding
- Blog: Simulations and active learning enable efficient identification of an experimentally-validated broad coronavirus inhibitor
- Blog: Virtual screening of DrugBank database for hERG blockers using topological Laplacian-assisted AI models
- Blog: SInCRe - structural interactome computational resource for Mycobacterium tuberculosis
- Blog: ComplexEye: a multi-lens array microscope for high-throughput embedded immune cell migration analysis
- Blog: NEBULA: Neural Empirical Bayes Under Latent Representations for Efficient and Controllable Design of Molecular Libraries
- Blog: Colorectal cancer drug target prediction using ontology-based inference and network analysis
- Blog: A Foundational Multi-Modal Knowledge Graph for Pancreatic Cancer Drug Effects Prediction
- Blog: Molecule generation for drug design: A graph learning perspective
- Blog: Assessment of the embryotoxicity of four Chinese herbal extracts using the embryonic stem cell test
- Blog: Bayesian Optimization in the Latent Space of a Variational Autoencoder for the Generation of Selective FLT3 Inhibitors
- Blog: Leveraging Generative AI to Prioritize Drug Repurposing Candidates: Validating Identified Candidates for Alzheimer's Disease in Real-World Clinical Datasets
- Blog: A review of transformer models in drug discovery and beyond
- Blog: The cornucopia of meaningful leads: Applying deep adversarial autoencoders for new molecule development in oncology
- Blog: DrugChat: Towards Enabling ChatGPT-Like Capabilities on Drug Molecule Graphs
- Blog: Deep generative model for drug design from protein target sequence
- Blog: UniMatch: Universal Matching from Atom to Task for Few-Shot Drug Discovery
- Blog: <i>In silico</i> design of immunogenic antigen cocktail via affinity maturation-guided optimization
- Blog: Geometric-informed GFlowNets for Structure-Based Drug Design
- Blog: Machine Learning Small Molecule Properties in Drug Discovery
- Blog: Comparison of seven in silico tools for evaluating of daphnia and fish acute toxicity: case study on Chinese Priority Controlled Chemicals and new chemicals
- Blog: The Impact of Computational Drug Discovery on Society
- Blog: Uncertainty Quantification and Interpretability for Clinical Trial Approval Prediction
- Blog: Machine-learning repurposing of DrugBank compounds for opioid use disorder
- Blog: DrugEx: Deep Learning Models and Tools for Exploration of Drug-Like Chemical Space
- Blog: Towards the prediction of drug solubility in binary solvent mixtures at various temperatures using machine learning
- Blog: Automated spheroid generation, drug application and efficacy screening using a deep learning classification: a feasibility study
- Blog: A Comparison of Embedding Aggregation Strategies in Drug-Target Interaction Prediction
- Blog: Machine Learning-Guided Prediction of Antigen-Reactive In Silico Clonotypes Based on Changes in Clonal Abundance through Bio-Panning
- Blog: Geometric Deep Learning for Structure-Based Ligand Design
- Blog: Causal Intervention for Measuring Confidence in Drug-Target Interaction Prediction
- Blog: Accelerating Antibiotic Discovery with Large Language Models and Knowledge Graphs
- Blog: Developing novel ligands with enhanced binding affinity for the sphingosine 1-phosphate receptor 1 using machine learning
- Blog: Robust task-specific adaption of models for drug-target interaction prediction
- Blog: Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal
- Blog: A new molecular simulation software package – Peking University Drug Design System (PKUDDS) for structure-based drug design
- Blog: CONTRABASS: exploiting flux constraints in genome-scale models for the detection of vulnerabilities
- Blog: DAPredict: a database for drug action phenotype prediction
- Blog: Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking
- Blog: Computer-Aided Molecular Modeling Study on Antibody Recognition of Small Molecules: An Immunoassay for Triazine Herbicides
- Blog: Target-Specific and Selective Drug Design for COVID-19 Using Deep Generative Models
- Blog: Development and Validation of a UPLC-MS/MS Method for the Quantification of Amantadine in Rat Plasma: Application to a Pharmacokinetic Study Under High-Altitude Hypoxia and Mechanistic Insights
- Blog: An AI-Driven Framework for Discovery of BACE1 Inhibitors for Alzheimer’s Disease
Showing 60 of 187 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_drug_discovery_inefficiency_07d1f045,
title = {drug discovery inefficiency},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/drug-discovery-inefficiency/rdr_07d1f045d71842a3b10205d91c607062},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-20},
}This exact version (version 1, frozen text):
@misc{lacuna_drug_discovery_inefficiency_07d1f045_v1,
title = {drug discovery inefficiency},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/drug-discovery-inefficiency/rdr_07d1f045d71842a3b10205d91c607062/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-20},
}